InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
-0.46%
)
US TECH 100
17,162.80
(
0.60%
)
Dow Jones
38,085.80
(
-0.98%
)
Brent Oil
88.17
(
0.02%
)
Bitcoin
64,276.81
(
-0.32%
)
Post# of 196
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DocLee

Send PM Follow Ignore
Followers 25
Posts 545
Boards Moderated 0
Alias Born 06/11/2011

DocLee

Re: None

Sunday, 12/11/2011 1:42:11 PM

Sunday, December 11, 2011 1:42:11 PM

Post# of 196
Clinical Trials Provide Further Evidence for Blinatumomab's Efficacy.

Clinical trial results were presented at the latest Annual Meeting of the American Society of Hematology and confirm that blinatumomab induces durable responses in patients who have relapsed on other forms of treatment. Additionally, the treatment is nowhere near as toxic as current forms of treatment.
Blinatumomab Efficacy - further evidence from Clinical Trials
The drug is proving itself and this can only be good for the SP.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up